I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
about
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: study protocol for a randomised clinical trial.Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza in 2015-2016: a hospital-based test-negative case-control study in Lithuania.Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/17.2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children.Important changes in the timing of influenza epidemics in the WHO European Region over the past 20 years: virological surveillance 1996 to 2016.Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study.Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically-attended influenza: results of the European I-MOVE multicentre test-negative case-control study, 2011/12-2016/17.Importance of timely monitoring of seasonal influenza vaccine effectiveness.Clinical Advances in Viral-Vectored Influenza VaccinesThe Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly PeoplePrevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza SeasonTimescales of influenza A/H3N2 antibody dynamics
P2860
Q37355265-FE517C92-E2FF-4098-905C-3482DE3CF316Q37635329-4AA60B3D-48F7-4975-AA0B-2A33F083DDA1Q37660781-52E85738-0020-412B-AEE7-5612D72D73D6Q37708550-127A01E5-335C-4E36-A46B-689A0259E316Q38868293-445D3EEB-50BD-4A44-814B-29626147CE83Q39310460-9F6F359D-BD0C-40A3-B931-78D358B18EF9Q40068128-5A46CA05-E972-4FD4-8321-EEB6AAA3EFA6Q41919783-C2EDFCFE-7584-4367-8B89-E1176E3857F1Q47551798-511CEED3-5650-49A6-8741-3402DD7802D6Q47583920-2AF3582C-8235-4A3A-8714-C1DCEC6944F9Q49215489-18654A7B-FEBD-40DD-94C1-119DA4F74AEAQ49400944-3275A97A-9A3C-4CCD-A28F-FD18D120872BQ52805071-077B3C75-F2E6-4638-B92E-AF7A1C6A2E20Q53112592-1D3A7B08-CFDF-46D4-A929-A91A125B0304Q57094631-A36CA921-1AB6-41CC-8BBF-D9C12F667D52Q57792424-906527AE-CDA5-4E5F-B6A1-5D8A27FDD961Q58709341-8359BC6C-2F79-4220-BBCB-A2BCDF7119A7Q58734451-17D68FD8-135F-4E69-A597-C16A5538AB77
P2860
I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
I-MOVE multicentre case-contro ...... easing time since vaccination?
@en
I-MOVE multicentre case-contro ...... easing time since vaccination?
@nl
type
label
I-MOVE multicentre case-contro ...... easing time since vaccination?
@en
I-MOVE multicentre case-contro ...... easing time since vaccination?
@nl
prefLabel
I-MOVE multicentre case-contro ...... easing time since vaccination?
@en
I-MOVE multicentre case-contro ...... easing time since vaccination?
@nl
P2093
P2860
P50
P1433
P1476
I-MOVE multicentre case-contro ...... easing time since vaccination?
@en
P2093
Alain Moren
Alin Gherasim
Annicka Reuss
Antonino Bella
Ausenda Machado
Beatrix Oroszi
Chris Robertson
Emilia Lupulescu
Esther Kissling
I-MOVE case–control study team
P2860
P356
10.2807/1560-7917.ES.2016.21.16.30201
P577
2016-04-01T00:00:00Z